ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $341,000 | -61.6% | 221,154 | -0.7% | 0.00% | -100.0% |
| Q1 2019 | $887,000 | +51.6% | 222,744 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $585,000 | -64.1% | 221,453 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $1,629,000 | +5.0% | 221,668 | +0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,551,000 | -25.5% | 221,568 | -1.0% | 0.00% | -50.0% |
| Q1 2018 | $2,082,000 | +24.0% | 223,848 | +0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,679,000 | -29.5% | 223,808 | +0.1% | 0.00% | 0.0% |
| Q3 2017 | $2,381,000 | -6.8% | 223,586 | -0.2% | 0.00% | -33.3% |
| Q2 2017 | $2,555,000 | +6.8% | 224,101 | +0.7% | 0.00% | +50.0% |
| Q1 2017 | $2,393,000 | -5.7% | 222,641 | +0.0% | 0.00% | -33.3% |
| Q4 2016 | $2,538,000 | -8.3% | 222,630 | +0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,767,000 | +9.6% | 222,610 | -0.3% | 0.00% | 0.0% |
| Q2 2016 | $2,524,000 | -11.7% | 223,180 | +0.0% | 0.00% | 0.0% |
| Q1 2016 | $2,859,000 | -54.5% | 223,154 | +0.0% | 0.00% | -57.1% |
| Q4 2015 | $6,279,000 | +45.2% | 223,121 | -0.0% | 0.01% | +40.0% |
| Q3 2015 | $4,323,000 | -36.1% | 223,156 | +0.0% | 0.01% | -28.6% |
| Q2 2015 | $6,766,000 | – | 223,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $14,025,000 | 1.27% |
| Ikarian Capital, LLC | 3,638,000 | $9,968,000 | 0.75% |
| Rubric Capital Management LP | 871,100 | $2,387,000 | 0.38% |
| Burrage Capital Management LLC | 135,898 | $363,000 | 0.36% |
| Soleus Capital Management, L.P. | 81,200 | $222,000 | 0.26% |
| Artal Group S.A. | 1,000,000 | $2,740,000 | 0.12% |
| BOOTHBAY FUND MANAGEMENT, LLC | 497,857 | $1,364,000 | 0.11% |
| Alambic Investment Management, L.P. | 10,700 | $29,000 | 0.07% |
| LORD, ABBETT & CO. LLC | 1,688,490 | $4,627,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 530,952 | $1,455,000 | 0.02% |